Cardinal Health, Inc. (CAH) — Fair Value Analysis
Base-case fair value (P50): $266.12 · Current price: $238.94 · Verdict: Fairly Valued
The Verdict on CAH
Cardinal Health (CAH) appears significantly undervalued according to our Monte Carlo simulations. With the stock currently trading at $238.94, our median fair value (P50) model indicates a target of $266.12. This translates to a substantial +11.4% upside potential from the current market price. Our analysis consistently points to CAH being undervalued within the Healthcare sector, suggesting a disconnect between its operational strength and its market valuation. This valuation gap, identified through thousands of forward-looking scenarios, positions CAH as a compelling opportunity for investors seeking exposure to the sector.
How CAH stacks up against Healthcare
Cardinal Health distinguishes itself with a "strong" quality tier, reflecting robust operational and financial health relative to its Healthcare sector peers. This strong fundamental profile underpins the conviction behind our fair value assessment. While the stock trades at $238.94, its intrinsic value, as derived from comprehensive Monte Carlo modeling, suggests it should be trading significantly higher at $266.12. This robust quality tier supports the projected +11.4% upside, indicating that CAH is not just undervalued, but fundamentally sound within a demanding industry landscape. The sector’s dynamics often mask individual stock strengths, but our simulations highlight CAH’s distinct advantage.
What this means for investors
For investors, the current valuation of Cardinal Health at $238.94 against a projected fair value of $266.12 presents a clear opportunity. The +11.4% upside, combined with a "strong" quality tier, suggests a favorable risk-reward profile. While our simulations model a wide range of potential outcomes, including downside scenarios and more aggressive bull cases, the median fair value firmly indicates undervaluation. This granular insight into CAH’s intrinsic worth, as processed by FairCurve’s advanced algorithms, empowers informed decision-making. Sign up for FairCurve to see the full bear/bull distribution and track CAH's fair value as new fundamentals are released.
Frequently Asked Questions
Is CAH overvalued or undervalued right now?
Based on our Monte Carlo simulations, Cardinal Health (CAH) is currently undervalued. Its median fair value (P50) is $266.12, significantly above its current trading price of $238.94.
What is the bear case and bull case for CAH?
The full Monte Carlo distribution, including specific bear (P10) and bull (P90) targets, along with the probability of upside, is available to users with a free FairCurve account. We do not provide specific dollar values for these scenarios publicly.
How does FairCurve calculate CAH's fair value?
FairCurve calculates CAH's fair value using advanced Monte Carlo simulations, running thousands of forward-looking financial scenarios to derive a probabilistic distribution of potential intrinsic values.
How can I track CAH's fair value as it changes?
You can add CAH to a free FairCurve watchlist to receive daily updates on its fair value and get instant re-valuation notifications whenever new earnings or significant fundamental data are released.